A study analyzing primary MM biopsies found a significant correlation between FcRL5 mRNA expression and 1q21 gain, suggesting that the 1q21 gain can lead to FcRL5 overexpression in high-risk MM patients (188, 190). This evidence concerns the gene FCRL5 and Miyoshi myopathy.